Key result
Percutaneous extraction of an inadvertently placed LV lead after dabigatran proves uncomplicated without neurologic events.
Why the study?
Malpositioned pacemaker leads in the left ventricle carry a risk of thromboembolic events, making prompt identification and early management critical.
Case Report (n=1)
Demonstrates the feasibility and safety of percutaneous extraction of a malpositioned LV pacemaker lead following dabigatran treatment.
Answers are grounded in this paper and cite their sources.
May support dabigatran pretreatment before extracting malpositioned LV leads; leaves open need for prospective data.
Malpositioned pacemaker lead in the left ventricle (LV) is a rare procedural complication, which causes a special risk of thromboembolic events. Hence, prompt identification and early management of misplaced leads inside the LV is critical. Herein, we present a case of malpositioned pacemaker lead with transient ischemic attacks after the pacemaker implantation. The misplaced ventricular lead was discovered during regular echocardiography. Both leads were extracted percutaneously after dabigatran treatment. To our knowledge, this is the first report of uncomplicated percutaneous extraction of an inadvertently placed LV lead after dabigatran treatment. No neurologic events during a follow-up of 4 years.
No takes yet. Share an insight, caveat, or question.
Farouq et al. (2022) conducted a case report in Malpositioned pacemaker lead in the left ventricle (n=1). Percutaneous extraction after dabigatran treatment was evaluated on Neurologic events. Percutaneous extraction of an inadvertently placed left ventricular pacemaker lead after dabigatran treatment was uncomplicated, with no neurologic events during a 4-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: